Citations 1

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1132

10.1001/jamaoncol.2019.1029 | PMID 31194225